Variant report
Variant | esv3368032 |
---|---|
Chromosome Location | chr4:76825803-76826299 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:0)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
No data |
No data |
No data |
No data |
No data |

No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs35388289 | chr4:76825819-76825820 | Weak transcription Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | mRNA abundance |
2 | rs34497607 | chr4:76825822-76825823 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
3 | rs34903442 | chr4:76825825-76825826 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
4 | rs113791909 | chr4:76825830-76825831 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
5 | rs13115160 | chr4:76825831-76825832 | Weak transcription Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
6 | rs59462849 | chr4:76825834-76825835 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
7 | rs534569960 | chr4:76825837-76825838 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
8 | rs554191498 | chr4:76825846-76825847 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
9 | rs139703248 | chr4:76825858-76825859 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
10 | rs113958826 | chr4:76825859-76825860 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
11 | rs575484120 | chr4:76825927-76825928 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
12 | rs113259785 | chr4:76825950-76825951 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
13 | rs146826626 | chr4:76826022-76826023 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
14 | rs563228071 | chr4:76826066-76826067 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
15 | rs148852355 | chr4:76826121-76826122 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
16 | rs542809488 | chr4:76826204-76826205 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
17 | rs562174106 | chr4:76826217-76826218 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
18 | rs573727075 | chr4:76826219-76826220 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
19 | rs74511942 | chr4:76826228-76826229 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
20 | rs541386332 | chr4:76826230-76826231 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
21 | rs542435512 | chr4:76826240-76826241 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Acute lymphoblastic leukemia | 22237106 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Chordoma | 21602918 | CNVD |
HIV/AIDS | 22032296 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Neuroblastoma | 18923191 | CNVD |
Thoracic aortic aneurysm | 21092924 | CNVD |
Intellectual disability | 22102821 | CNVD |
Autism | 22495311 | CNVD |
Breast cancer | 21858162 | CNVD |
Small bowel adenocarcinoma | 21586687 | CNVD |
Gastric cancer | 21586687 | CNVD |
lymphocytic leukemia | 21291569 | CNVD |
Basal cell lymphoma | 16317097 | CNVD |
Diffuse large b-cell lymphoma | 16317097 | CNVD |
Melanoma | 18172304 | CNVD |
Acute lymphoblastic leukemia | 20067559 | CNVD |
Breast cancer | 17603634 | CNVD |
Glioblastoma multiforme | 21922591 | CNVD |
Parkinson disease | 21956041 | CNVD |
Mental retardation | 20522426 | CNVD |
delayed speech | 20522426 | CNVD |
growth disorder | 20522426 | CNVD |
Hepatocellular carcinoma | 16750200 | CNVD |
Myxofibrosarcoma | 16751306 | CNVD |
Esophageal squamous carcinoma | 18350619 | CNVD |
Parkinson disease | 18923514 | CNVD |
Non-syndromic sensorineural hearing loss | 15273396 | CNVD |
Cancer | 21183584 | CNVD |
Breast cancer | 16272173 | CNVD |
Colorectal cancer | 19359472 | CNVD |
Malignant mesothelioma | 18160781 | CNVD |
Medulloblastoma | 18056178 | CNVD |
Multiple myeloma | 17077331 | CNVD |
Pleural malignant mesothelioma | 18160781 | CNVD |
Primary mediastinal b-cell lymphoma | 17728785 | CNVD |
Oral squamous cell carcinoma | 17134496 | CNVD |
4q-syndrome | 17576883 | CNVD |
Cancer | 21637783 | CNVD |
Non-syndromic sensorineural hearing loss | 18471307 | CNVD |
Colorectal cancer | 20709793 | CNVD |
Muscular dystrophy | 21149563 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Breast cancer | 21264507 | CNVD |
Glioblastoma multiforme | 19960244 | CNVD |
Glioblastoma multiforme | 17387387 | CNVD |
Hepatocellular carcinoma | 22174799 | CNVD |
Liposarcoma | 21253554 | CNVD |
Oligodendroglial tumors | 17285580 | CNVD |
Cervical cancer | 21062161 | CNVD |
Metanephric adenoma | 20802469 | CNVD |
Breast cancer | 16608533 | CNVD |
Adenoid cystic carcinoma | 18698036 | CNVD |
Lung cancer | 19208797 | CNVD |
Wilms tumour | 21544195 | CNVD |
Breast cancer | 21785460 | CNVD |
Basal cell lymphoma | 17170743 | CNVD |
Follicular lymphoma | 17170743 | CNVD |
Chronic lymphocytic leukemia | 20421269 | CNVD |
Myelodysplastic syndrome | 21251322 | CNVD |
Multiple myeloma | 17550852 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Lung cancer | 18438408 | CNVD |
Chronic lymphocytic leukemia | 18922857 | CNVD |
Cancer | 22429812 | CNVD |
Multiple myeloma | 16616336 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Breast cancer | 21364760 | CNVD |
Autism | 18414403 | CNVD |
Myelofibrosis | 22110671 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr4:76821600-76831000 | Enhancers | Primary monocytes fromperipheralblood | blood |
2 | chr4:76823000-76836600 | Weak transcription | Spleen | Spleen |
3 | chr4:76823600-76835000 | Weak transcription | Primary T helper cells PMA-I stimulated | -- |
4 | chr4:76823800-76826200 | Enhancers | Monocytes-CD14+_RO01746 | blood |
5 | chr4:76823800-76835000 | Weak transcription | Primary mononuclear cells fromperipheralblood | Blood |
6 | chr4:76824000-76835200 | Weak transcription | Primary Natural Killer cells fromperipheralblood | blood |
7 | chr4:76824800-76841000 | Weak transcription | Primary T helper memory cells from peripheral blood 1 | blood |
8 | chr4:76825600-76827200 | Weak transcription | iPS DF 19.11 Cell Line | embryonic stem cell |
9 | chr4:76826200-76827200 | Weak transcription | Monocytes-CD14+_RO01746 | blood |